Digistain Presents Key Research Findings at the San Antonio Breast Cancer Symposium 2024

Last week, we were proud to present two abstracts at the San Antonio Breast Cancer Symposium 2024.

The first abstract presented data from Charing Cross Hospital on Digistain and metastasis-free survival.

The second abstract focused on assessing Digistain’s robustness by assessing its performance against variations in tissue fixation time, reporting its performance across a range of fixation times.

We continue to work to provide recurrence-risk information to clinicians and patients.

 

https://sabcs.org/Call-for-Abstracts-2024

P4-07-29: Analytical Validity of the Digistain Test in the Face of Variable Fixation Times: A Study from Charing Cross Hospital

 

Supported by:

royal society logo
NIHR logo
cancer research uk logo
BIVDA logo

Subscribe to leading news and insights

To stay updated about Digistain’s developments, enter your details opposite. We promise only to send you important news.